Prof Abdulrazaq Garba Habib

MBBS, MSc Epid [Lond], MRCP (UK), FWACP, FRCP [Lond], FAMS [Infect Dis], CTH) is an infectious and tropical diseases physician, public health implementer, epidemiologist, educator and a professor since 2009. He has interests in Global Health (including community acquired infections, antimicrobial resistance, emerging infections [Ebola, SARS], Human Immunodeficiency Virus (HIV) infections, Immunology, clinical epidemiology, tropical diseases, Snakebite envenoming and health economics). He trained and supervised several masters and PhD students and medical fellows/residents. He is a member of research workgroups including Infectious Diseases Work Group;

Health Economics and Outcomes Research; Clinical Epidemiology Workgroup; and the Venom Antivenom Research Group (VASP) at BUK. He is a co-Investigator in the UK’s ‘NIHR Group on African Snakebite Research’, comprising Professor Habib and VASP-BUK Nigeria, two Units in Cameroon and Kenya with headquarters at Liverpool School of Tropical Medicine and Hygiene, UK. He has published 128 papers, has had 1024 citations and has contributed five chapters in books and is an editor to a monograph on Clinical Toxinology (by Springer) and to three jjournals including a BMC international journal.

He is member/fellow of the International Society of Toxinology, International AIDS Society, International Union Against Tuberculosis and Lung Diseases, International Society for Infectious Diseases and Royal Society for Tropical Medicine and Hygiene (inactive subscription). He was acting Chair of Friends for Global Health, affiliated to Vanderbilt Institute for Global Health, University of Vanderbilt, USA. He is a Trustee of the Toxinology Society of Nigeria (TSN). Dr. Habib is an International advisor to the Royal College of Physicians London (UK), member Board of Directors of the Melbourne-based Global Snakebite Initiative (GSI) and member West African Academic Alliance of the Accordia Foundation and West African Infectious Diseases Institute (WAIDI).